Clinical Trials Browser

Phase 2 × Fallopian Tube Neoplasms × fluzoparib × Clear all

NCT06161272 2023-12-07

Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi

Phase 2 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06063070 2023-10-02

First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer

Phase 2 Not yet recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms